Abstract
BackgroundA tight control strategy is necessary for an optimal management of early rheumatoid arthritis (ERA). However, it is not sufficient because there is a huge need of biomarkers in order...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have